GlassScriptPhysician profile
Sanjay P Patel
NPI 1518991900
$2,241.42
in general payments reported to CMS, 2019-2025
13 companies · $38.18 in 2025
The $38.18 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,462 · 2020: $70.56 · 2021: $43.48 · 2022: $296 · 2023: $124 · 2024: $207 · 2025: $38.18.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $370.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $369.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $1,486.45 | 2019-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $278.32 | 2021-2024 | |
| E.R. Squibb & Sons, L.L.C. | $111.81 | 2019-2022 | |
| Lilly USA, LLC | $103.91 | 2023-2024 | Mounjaro |
| Idorsia Pharmaceuticals US INC | $60.36 | 2022-2024 | Quviviq |
| Allergan, INC. | $40.00 | 2020 | |
| Boston Scientific Corporation | $35.32 | 2019-2021 | |
| Astrazeneca Pharmaceuticals LP | $32.70 | 2024 | Farxiga |
| Horizon Therapeutics Plc | $26.65 | 2023 | Krystexxa |
| Abbott Laboratories | $21.73 | 2024 | Freestyle Libre 3 |
| Alcon Vision LLC | $17.07 | 2022 | |
| Esperion Therapeutics, INC. | $14.93 | 2023 | Nexletol |
| Amarin Pharma, INC. | $12.17 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sanjay Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.